Con nuestra iniciativa Hemato on the GO tiene a la mano los avances más recientes y las innovaciones científicas más relevantes en el campo de la hematología. A continuación junto a Peter Schuld, Director Internacional de Medical Affairs en Novartis les contamos de que se trata esta iniciativa.
Dra. Natalia Aranguiz, Chile - Día 4
Videos: FA-11215946 | Junio 2024
Referencias
Video Dr. Miguel Ángel Rodriguez: 1. Presentation Abstract 558321 - Novel treatment approaches: elevating the need for tolerability in treatment innovations - Susanne Saussele https://congress-apps.ehaweb.org/eha2024/en-GB/pag/presentation/558321
1. Presentation Abstract 558322 - Tolerability as the foundation: optimizing outcomes from the start of the treatment journey - Timothy Hughes https://congress-apps.ehaweb.org/eha2024/en-GB/pag/presentation/558322
Video Dra. Soledad Undurraga: 1. Presentation Abstract 557688 - ELN recommendations 2024 - Henrik Hjorth-Hansen https://congress-apps.ehaweb.org/eha2024/en-GB/pag/presentation/557688
Video Dra. Ana Nadal: 1. Presentation Abstract 557687 - The new treatment paradigm: Improving quality of life in CML - Fabio Efficace https://congress-apps.ehaweb.org/eha2024/en-GB/pag/presentation/557687
Video Dra. Natalia Aranguiz: 1. Presentation Abstract 557721 - When are alternative therapies indicated? - Andreas Hochhaus https://congress-apps.ehaweb.org/eha2024/en-GB/pag/presentation/557721